EUVIMEDEUVIMED entdecken
Crossref

SGLT2 inhibitors and contrast-associated acute kidney injury

Richard Solomon

Kardiologia Polska · 2024

DOI: 10.33963/v.kp.98717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kardiologia Polska, 2024. Verfasst von Richard Solomon. Beteiligte Einrichtung: University of Vermont Larner College of Medicine, Burlington, Vermont, United States. richard.solomon@uvmhealth.org. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Acute Kidney Injury, Diabetes Mellitus, Type 2.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsAcute Kidney InjuryDiabetes Mellitus, Type 2HumansHypoglycemic AgentsKidney

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic Agents

Autor:innen und Institutionen

  • University of Vermont Larner College of Medicine, Burlington, Vermont, United States. richard.solomon@uvmhealth.org.

Zitieren

APA

Solomon, R. (2024). SGLT2 inhibitors and contrast-associated acute kidney injury. Kardiologia Polska. https://doi.org/10.33963/v.kp.98717

Vancouver

Solomon R. SGLT2 inhibitors and contrast-associated acute kidney injury. Kardiologia Polska. 2024. doi:10.33963/v.kp.98717

BibTeX
@article{Solomon2024,
  author = {Solomon, Richard},
  title = {SGLT2 inhibitors and contrast-associated acute kidney injury},
  journal = {Kardiologia Polska},
  year = {2024},
  doi = {10.33963/v.kp.98717}
}
Kostenlos starten →